STUDIES OF EPSTEIN-BARR VIRUS (EBV)-ASSOCIATED NUCLEAR ANTIGEN .1. ASSAY IN HUMAN LYMPHOBLASTOID CELL LINES BY DIRECT AND INDIRECT DETERMINATION OF IGG-I-125 BINDING

被引:10
作者
BROWN, TDK [1 ]
ERNBERG, I [1 ]
KLEIN, G [1 ]
机构
[1] KAROLINSKA INST,DEPT TUMOUR BIOL,S-10401 STOCKHOLM,SWEDEN
关键词
D O I
10.1002/ijc.2910150410
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:606 / 616
页数:11
相关论文
共 19 条
[1]   DETECTION OF EPSTEIN-BARR VIRUS (EBV)-ASSOCIATED NUCLEAR ANTIGEN IN HUMAN LYMPHOBLASTOID CELL LINES BY MEANS OF AN I-125-IGG BINDING ASSAY [J].
BROWN, TDK ;
ERNBERG, I ;
LAMON, EW ;
KLEIN, G .
INTERNATIONAL JOURNAL OF CANCER, 1974, 13 (06) :785-794
[2]   CELLULAR REACTIONS AGAINST BURKITT LYMPHOMA CELLS .3. EFFECTOR CELL ACTIVITY OF LEUKOCYTES STIMULATED IN-VITRO WITH AUTOCHTHONOUS CULTURED LYMPHOMA CELLS [J].
GOLUB, SH ;
HEWETSON, JF ;
SVEDMYR, EAJ ;
SINGH, S ;
KLEIN, G .
INTERNATIONAL JOURNAL OF CANCER, 1972, 10 (01) :157-&
[3]   ANTIBODIES UNRELATED TO EPSTEIN-BARR VIRUS IN HUMAN SERA WHICH PRECIPITATE SOLUBLE COMPONENTS OF CULTURED LYMPHOBLASTS [J].
GUERRA, A ;
KOLDOVSKY, U ;
HENLE, W .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 53 (05) :1193-1200
[4]   PREPARATION OF IODINE-131 LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC ACTIVITY [J].
HUNTER, WM ;
GREENWOOD, FC .
NATURE, 1962, 194 (4827) :495-&
[5]   RELATIONSHIP BETWEEN SENSITIVITY OF EBV-CARRYING LYMPHOBLASTOID LINES TO SUPERINFECTION AND INDUCIBILITY OF RESIDENT VIRAL GENOME [J].
KLEIN, G ;
DOMBOS, L .
INTERNATIONAL JOURNAL OF CANCER, 1973, 11 (02) :327-337
[6]  
KLEIN G, 1974, JNCI-J NATL CANCER I, V53, P1645
[7]   CONTINUOUS LYMPHOID-CELL LINES WITH CHARACTERISTICS OF B-CELLS (BONE-MARROW-DERIVED), LACKING EPSTEIN-BARR VIRUS GENOME AND DERIVED FROM 3 HUMAN LYMPHOMAS [J].
KLEIN, G ;
LINDAHL, T ;
JONDAL, M ;
LEIBOLD, W ;
MENEZES, J ;
NILSSON, K ;
SUNDSTROM, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (08) :3283-3286
[8]   CYTOTOXICITY OF A FACTOR ISOLATED FROM HUMAN SPLEEN [J].
LOZZIO, CB ;
LOZZIO, BB .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1973, 50 (02) :535-538
[9]  
MILLER G, 1971, P SOC EXP BIOL MED, V137, P1459
[10]  
MINOWADA J, 1972, J NATL CANCER I, V49, P891